Correlation Between Lumos Pharma and Candel Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lumos Pharma and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lumos Pharma and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lumos Pharma and Candel Therapeutics, you can compare the effects of market volatilities on Lumos Pharma and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lumos Pharma with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lumos Pharma and Candel Therapeutics.

Diversification Opportunities for Lumos Pharma and Candel Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Lumos and Candel is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Lumos Pharma and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Lumos Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lumos Pharma are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Lumos Pharma i.e., Lumos Pharma and Candel Therapeutics go up and down completely randomly.

Pair Corralation between Lumos Pharma and Candel Therapeutics

If you would invest  917.00  in Candel Therapeutics on December 25, 2024 and sell it today you would lose (51.00) from holding Candel Therapeutics or give up 5.56% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Lumos Pharma  vs.  Candel Therapeutics

 Performance 
       Timeline  
Lumos Pharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Lumos Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy primary indicators, Lumos Pharma is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Candel Therapeutics 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Candel Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady fundamental indicators, Candel Therapeutics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Lumos Pharma and Candel Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lumos Pharma and Candel Therapeutics

The main advantage of trading using opposite Lumos Pharma and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lumos Pharma position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.
The idea behind Lumos Pharma and Candel Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities